İçeriğe geç
akaturk Akademik ölçüm

Akademisyen profili · DOÇENT

HAKKI ONUR KIRKIZLAR

TRAKYA ÜNİVERSİTESİ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Hematoloji (İç Hastalıkları)
  • TIP FAKÜLTESİ
  • DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
Makale YÖKSİS 63
Proje 0
Kitap 0
Bildiri 0
Patent 0
Sanatsal 0
Scopus (SJR)
Q1 2 Q2 14 Q3 14 Q4 14
WoS (JCR)
Q1 5 Q2 4 Q3 16 Q4 22
TR Index 24 makale

Scopus (SJR)

WoS (JCR)

TR Index

24 makale

Toplam 63 yayın

Makaleler

  1. 2025 Comprehensive analysis of FLT3-mutated patients with acute myeloid leukemia with updated 2022 European LeukemiaNet recommendations: insights from the Turkish AML registry project BMC Cancer DOI 10.1186/s12885-025-14987-z
  2. 2025 Clinical Characteristics, Treatment Approaches, and Survival Predictors in Adult Acute Myeloid Leukemia: Interim Results from the Turkish Society of Hematology AML Registry Journal of Clinical Medicine DOI 10.3390/jcm14207367
  3. 2025 Evaluation of Venous Thromboembolism in Multiple Myeloma and Its Impact on Mortality Medical Bulletin of Haseki DOI 10.4274/haseki.galenos.2025.21931
  4. 2025 Gastrointestinal Manifestations of Mature B Cell Neoplasms: Single Center Experiences from the Collective Perspective of Hematology and Pathology Meandros Medical And Dental Journal DOI 10.69601/meandrosmdj.1611578
  5. 2025 Rare Nodular Hepatosplenic Involvement in Multiple Myeloma: FDG PET/CT and MRI Correlation with Treatment Response Nuclear Medicine and Molecular Imaging DOI 10.1007/s13139-025-00971-9
  6. 2025 Analysis of Predictors of Progression-Free Survival and Early Response in Young Adult Classical Hodgkin Lymphoma Hitit Medical Journal DOI 10.52827/hititmedj.1652673
  7. 2024 A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients Leukemia & Lymphoma DOI 10.1080/10428194.2024.2395458
  8. 2024 Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis Turkish Journal of Hematology DOI 10.4274/tjh.galenos.2024.2023.0450
  9. 2024 Myeloproliferative Neoplasm Symptom Assessment Total Symptom Score (MPN-SAF TSS) in Chronic Myeloproliferative Neoplasms, Related with Genetic Burden, and Thrombosis Turkish Journal of Hematology DOI 10.4274/tjh.galenos.2024.2024.0011
  10. 2023 Incidence and predisposing factors of infection in patients treated with hypomethylating agents Leukemia Research DOI 10.1016/j.leukres.2023.107043
  11. 2023 Therapeutic plasma exchange in hyperthyroidism prior to surgery Journal of Endocrinological Investigation DOI 10.1007/s40618-022-01897-1
  12. 2022 Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag? Turkish Journal of Hematology DOI 10.4274/tjh.galenos.2021.2021.0183
  13. 2022 CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study Journal of Hematopathology DOI 10.1007/s12308-022-00523-6
  14. 2022 The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study Annals of Hematology DOI 10.1007/s00277-022-04798-8
  15. 2022 The first case of peripheral T cell lyphoma with a CSF3R variant resulted in relapsing febrile neutropenia and aplastic anemia Journal of Hematopathology DOI 10.1007/s12308-022-00513-8
  16. 2022 Castleman Disease: A Multicenter Case Series from Turkey Turkish Journal of Hematology DOI 10.4274/tjh.galenos.2022.2021.0670
  17. 2022 Patient characteristics and management practices in chronic myeloid leukemia in Turkey: reflections from an expert meeting Expert Review of Hematology DOI 10.1080/17474086.2022.2044779
  18. 2022 Management of Patients with Factor VII Deficiency in Surgery: Single Center Experience Erciyes Medical Journal DOI 10.14744/etd.2021.30969
  19. 2022 Comparison of Hemophagocytic Lymphohistiocytosis Diagnostic Criteria in Malignancy-Associated Hemophagocytic Lymphohistiocytosis Patients Turkish Journal of Internal Medicine DOI 10.46310/tjim.1121064
  20. 2021 Pros and cons for fluorescent in situ hybridization, karyotyping and next generation sequencing for diagnosis and follow-up of multiple myeloma Balkan Journal of Medical Genetics DOI 10.2478/bjmg-2020-0020

Akademisyenlere dön